Wei-Chang Chen Selected Research

hairpin ribozyme

6/2009	[Construction of recombinant adenovirus vector expressing anti-VEGF hairpin ribozyme and human interleukin-24 and its cytotoxic effect on colon cancer HT-29 cells].
4/2009	[Construction of adenovirus expressing anti-vascular endothelial growth factor hairpin ribozyme and its inhibition of growth of colorectal cancer HT-29 cells].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Chang Chen Research Topics

Disease

10	Neoplasms (Cancer) 03/2017 - 10/2004
9	Stomach Neoplasms (Stomach Cancer) 10/2015 - 05/2008
4	Colonic Neoplasms (Colon Cancer) 11/2017 - 02/2007
4	Carcinoma (Carcinomatosis) 01/2014 - 02/2007
3	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 10/2004
2	Pancreatitis 03/2020 - 01/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018 - 01/2014
2	Flatulence 01/2013 - 01/2012
2	Ulcerative Colitis 01/2013 - 01/2012
2	Type 2 Diabetes Mellitus (MODY) 01/2013 - 01/2012
2	Esophageal Squamous Cell Carcinoma 10/2012 - 12/2010
2	Lymphatic Metastasis 09/2012 - 02/2007
2	Neoplasm Metastasis (Metastasis) 02/2007 - 10/2004
1	Inflammation (Inflammations) 03/2020
1	Colonic Polyps 11/2017
1	Fistula 01/2016
1	Crohn Disease (Crohn's Disease) 01/2016
1	Velopharyngeal Insufficiency 10/2015
1	Infections 04/2009
1	Hepatocellular Carcinoma (Hepatoma) 03/2009
1	Carcinogenesis 05/2008
1	Adenomatous Polyps 02/2007

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 12/2018 - 10/2004
6	Messenger RNA (mRNA)IBA 03/2017 - 10/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013 - 04/2009
3	HydrogenIBA 01/2013 - 01/2012
2	MicroRNAs (MicroRNA)IBA 11/2017 - 01/2014
2	Small Interfering RNA (siRNA)IBA 02/2013 - 09/2012
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2013 - 12/2010
2	CarbohydratesIBA 01/2013 - 01/2012
2	Acarbose FDA LinkGeneric 01/2013 - 01/2012
2	EnzymesIBA 01/2013 - 01/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 01/2012
2	Cyclin AIBA 10/2012 - 12/2010
2	SurvivinIBA 09/2012 - 10/2004
2	CD40 Ligand (CD40L)IBA 11/2011 - 09/2009
2	hairpin ribozymeIBA 06/2009 - 04/2009
1	salicylhydroxamic acid (SHAM)IBA 03/2020
1	Aldo-Keto ReductasesIBA 12/2018
1	Infliximab (Remicade)FDA Link 01/2016
1	Transcription Factors (Transcription Factor)IBA 10/2015
1	CDX2 Transcription FactorIBA 10/2015
1	Cytochromes c (Cytochrome c)IBA 01/2013
1	Fluorouracil (Carac)FDA LinkGeneric 01/2013
1	Celecoxib (Celebrex)FDA Link 01/2013
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2013
1	hydrogen rich salineIBA 01/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	Free RadicalsIBA 01/2013
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2013
1	CytokinesIBA 01/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2012
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 09/2012
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2012
1	Cell Cycle ProteinsIBA 12/2010
1	interleukin-24 (ST16)IBA 06/2009
1	VaccinesIBA 03/2009
1	Core Binding Factor Alpha 3 SubunitIBA 05/2008
1	DNA (Deoxyribonucleic Acid)IBA 05/2008
1	Transcription Factor 3IBA 05/2008
1	MethyltransferasesIBA 05/2008
1	beta CateninIBA 02/2007
1	Formaldehyde (Formol)FDA Link 02/2007
1	ParaffinIBA 02/2007
1	Cyclin D1IBA 02/2007
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2004
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2004

Therapy/Procedure

3	Therapeutics 01/2016 - 09/2012
2	Immunotherapy 03/2020 - 01/2013
1	Enteral Nutrition (Feeding, Tube) 01/2016
1	Prostheses and Implants (Prosthesis) 10/2015
1	Oral Surgery (Maxillofacial Surgery) 10/2015
1	Oral Administration 01/2013
1	Drug Therapy (Chemotherapy) 10/2012